Overview Personalized Insemination Treatment Study Status: Active, not recruiting Trial end date: 2021-10-01 Target enrollment: Participant gender: Summary This study is intended for women undergoing their first cycle of 3 intrauterine inseminations. All 3 inseminations will be personalized by using algorithms to determine the dose of study medication. Phase: N/A Details Lead Sponsor: Clinique OvoOVO R & DTreatments: Follicle Stimulating Hormone